Molecular modeling studies on nucleoside hydrolase from the biological warfare agent Brucella suis.

Authors: Mancini DT,Matos KS,da Cunha EF,Assis TM,Guimarães AP,França TC,Ramalho TC,
Address: Chemistry Department, Federal University of Lavras - Campus Universitário - UFLA, Lavras, Brazil.
Journal: J Biomol Struct Dyn.

Publication: 2012;30(1):125-36. doi: 10.1080/07391102.2012.674293.

abstract

Brucella suis is a dangerous biological warfare agent already used for military purposes. This bacteria cause brucellosis, a zoonosis highly infective and difficult to fight. An important selective target for chemotherapy against this disease is nucleoside hydrolase (NH), an enzyme still not found in mammals. We present here the first three-dimensional structure of B. suis NH (BsNH) and propose this enzyme as a Molecular target to the drug design in the fight against brucellosis. In addition, we performed molecular docking studies, aiming to analyze the three-dimensional positioning of nine known inhibitors of Chritidia fasciculata NH (CfNH) in the active sites of BsNH and CfNH. We also analyzed the main interactions of some of these compounds inside the active site of BsNH and the relevant factors to biological activity. These results, together with further molecular dynamics (MD) simulations, pointed out to the most promising compound as lead for the design of potential inhibitors of BsNH. Most of the docking and MD results corroborated to each other and the docking results also suggested a good correlation with experimental data.

Related Articles
Design of new chemotherapeutics against the deadly anthrax disease. Docking and molecular dynamics studies of inhibitors containing pyrrolidine and riboamidrazone rings on nucleoside hydrolase from Bacillus anthracis.
J Biomol Struct Dyn. 2011
Design of new chemotherapeutics against the deadly anthrax disease. Docking and molecular dynamics studies of inhibitors containing pyrrolidine and riboamidrazone rings on nucleoside hydrolase from Bacillus anthracis.
Guimarães AP, Oliveira AA, da Cunha EF, Ramalho TC, França TC. J Biomol Struct Dyn. 2011 Feb; 28(4):455-69.
Analysis of Bacillus anthracis nucleoside hydrolase via in silico docking with inhibitors and molecular dynamics simulation.
J Mol Model. 2011
Analysis of Bacillus anthracis nucleoside hydrolase via in silico docking with inhibitors and molecular dynamics simulation.
Guimarães AP, Oliveira AA, da Cunha EF, Ramalho TC, França TC. J Mol Model. 2011 Nov; 17(11):2939-51. Epub 2011 Feb 12.
Anti-virulence strategy against Brucella suis: synthesis, biological evaluation and molecular modeling of selective histidinol dehydrogenase inhibitors.
Org Biomol Chem. 2011
Anti-virulence strategy against Brucella suis: synthesis, biological evaluation and molecular modeling of selective histidinol dehydrogenase inhibitors.
Abdo MR, Joseph P, Mortier J, Turtaut F, Montero JL, Masereel B, Köhler S, Winum JY. Org Biomol Chem. 2011 May 21; 9(10):3681-90. Epub 2011 Apr 1.
Review Zinc metalloenzymes as new targets against the bacterial pathogen Brucella.
J Inorg Biochem. 2012
Review Zinc metalloenzymes as new targets against the bacterial pathogen Brucella.
Lopez M, Köhler S, Winum JY. J Inorg Biochem. 2012 Jun; 111:138-45. Epub 2011 Dec 1.
Review The innate immune response against Brucella in humans.
Vet Microbiol. 2002
Review The innate immune response against Brucella in humans.
Dornand J, Gross A, Lafont V, Liautard J, Oliaro J, Liautard JP. Vet Microbiol. 2002 Dec 20; 90(1-4):383-94.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.